Current Neuro-Oncology
Volume
27 Number 5
20 February 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 5, 20 February
Jiang K, Kalluri A, Odonkor M, Heinemann DM, Weber-Levine C, Raj
D, Materi J, Rakovec M, Pineda E, Redmond KJ, Romo C, Kamson DO,
Holdhoff M, Schreck KC, González Sánchez JJ,
Bettegowda C, Rincon-Torroella J.
Trends
in the Management of
Oligodendrogliomas: A Multinational and Multidisciplinary Survey
Study.
World Neurosurg. 2025 Feb 11:123716? doi:
10.1016/j.wneu.2025.123716? PMID:
39947316. Observational study˰
ˍ
Osawa S, Kawauchi D, Ohno M, Miyakita Y, Takahashi M, Yanagisawa
S, Fujita S, Tsuchiya T, Matsumi J, Sato T, Narita Y.
Outcomes
of awake surgery for recurrent glioblastoma: A single-institution
retrospective analysis.
J
Clin Neurosci. 2025 Feb 13;134:111113. doi:
10.1016/j.jocn.2025.111113? PMID:
39951833. Observational study. ˍ
Stone TJ, Pickles JC, Ogunbiyi O, Yasin SA, Taylor CA, Ahmed SW,
Chalker J, Dryden C, Slodkowska I, Pang E, Kristiansen M, Williams
R, Tutill H, Williams CA, Madhan GK, Forrest L, Brooks T, Hubank
M, Hughes D, Proszek P, Pietka G, Peat E, Hargrave D, Jacques TS.
The tumour microenvironment of
pilocytic astrocytoma evolves over time via enrichment for
microglia.
Acta
Neuropathol Commun. 2025 Feb 13;13(1):30. doi:
10.1186/s40478-024-01922-9. PMID:
39948623. Observational study. ˍ
Aduwo JY, McClelland S 3rd.
Censoring
Analysis of the INvestigating VorasiDenib In GliOma (INDIGO) Phase
III Randomized Controlled Trial.
Am
J Clin Oncol. 2025 Feb 14. doi:
10.1097/COC.0000000000001175. PMID:
39950862. Editorial. ˍ
RELATED
ARTICLE
Mellinghoff
IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J,
Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y,
Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick
W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA,
Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY,
Cloughesy TF.
Vorasidenib
in IDH1- or IDH2-Mutant Low-Grade Glioma.
N
Engl J Med.
2023 Jun 4. doi:
10.1056/NEJMoa2304194. PMID:
37272516. Interventional study. ˍ
Kiesel B, Borkovec M, Furtner J, Roetzer-Pejrimovsky T, Nenning
KH, Greutter L, Miller-Michlits Y, Widhalm G, Woehrer A.
Sex-specific differences in DNA
methylation defining prognostically relevant subgroups in
glioblastoma.
J
Neurosurg. 2025 Feb 14:1-10. doi:
10.3171/2024.9.JNS24665. PMID:
39951709. Laboratory investigation; Observational study˰
ˍ